Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$738.2M
Avg Funding
$29.5M
Global Reach
8
countries

Top Cities for Biopharma

Hong Kong
Rockville
Menlo Park
Newton
London
Paris

Recently Funded Companies

Export
Hong Kong, Hong Kong

Yuanbo Biotechnology is a provider of clever AI-driven cell manufacturing systems.

$1.3M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Rockville, United States

NeuroCytonix is a biomedical technology company that is centered on tissue creation and regeneration.

$4.0M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

$10.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Newton, United States

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

$82.5M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

London, United Kingdom

MultiplAI Health is a leveraging advances in genomics and artificial intelligence to develop universal remote screening.

$295K raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Paris, France

Enabling tomorrow's therapies manufacturing for today's patients, with sound

$2.8M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Houston, United States

Steer Bio is a biotechnology company that specializes in revitalizing cell-based medicines.

$18.2M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Expanded Access software for biopharmaceuticals

Mar 2025

Founder Contacts

30,000+ verified contacts

Lausanne, Switzerland

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

$3.8M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Long Beach, United States

Bakhu Holdings produces, manufactures, and sells cannabis-related byproducts — sometimes referred to in the industry as cannabinoids.

$1.0M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Boston, United States

Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.

$15.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

$100.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Frederiksberg, Denmark

Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.

$1.5M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Waltham, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

$30.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Boulder, United States

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

$100.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Toronto, Canada

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

$432K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.

$150.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Charlottetown, Canada

Our mission at Pegasus Biotech is to work with our clients to bring cutting edge innovation to the global human and animal health markets.

$360K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

$10.4M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Englewood, United States

Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.

$60.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Carlsbad, United States

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

$3.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Wroclaw, Poland

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

$17.7M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Waltham, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

$100.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

$20.0M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

MCAL Therapeutics is a biotechnology company that develops treatment for ophthalmic diseases.

$5.9M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Showing 326 to 350 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$29.5M
Total Funding Tracked
$738.2M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Menlo Park
2 companies$10.0M
2.Cambridge
2 companies$250.0M
3.Waltham
2 companies$130.0M
4.Hong Kong
1 companies$1.3M
5.Rockville
1 companies$4.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 14 | VCBacked